Posted by ABMN Staff on Mar 29th, 2024
Equities research analysts at StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a report released on Friday. The firm set a “sell” rating on the medical research company’s stock.
OpGen...
More of this article »